Swiss National Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Swiss National Bank’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-282,700	Closed	-$416K	–	2369
2025 Q1	$416K	Hold	282,700	–	–	﹤0.01%	2365
2024 Q4	$1.25M	Buy	282,700 +6,000	+2%	+$24.3K	﹤0.01%	2103
2024 Q3	$1.14M	Hold	276,700	–	–	﹤0.01%	2151
2024 Q2	$1.8M	Hold	276,700	–	–	﹤0.01%	1871
2024 Q1	$2.41M	Hold	276,700	–	–	﹤0.01%	1737
2023 Q4	$3.17M	Sell	276,700 -30,600	-10%	-$303K	﹤0.01%	1584
2023 Q3	$2.96M	Buy	307,300 +5,300	+2%	+$51.9K	﹤0.01%	1598
2023 Q2	$3.21M	Buy	302,000 +4,000	+1%	+$43K	﹤0.01%	1588
2023 Q1	$3.13M	Sell	298,000 -35,000	-11%	-$392K	﹤0.01%	1556
2022 Q4	$4.13M	Buy	333,000 +4,700	+1%	+$53.3K	﹤0.01%	1440
2022 Q3	$3.4M	Sell	328,300 -9,300	-3%	-$105K	﹤0.01%	1518
2022 Q2	$3.89M	Sell	337,600 -30,000	-8%	-$353K	﹤0.01%	1471
2022 Q1	$4.62M	Buy	367,600 +27,600	+8%	+$316K	﹤0.01%	1483
2021 Q4	$3.96M	Hold	340,000	–	–	﹤0.01%	1620
2021 Q3	$4.44M	Buy	340,000 +2,900	+0.9%	+$37.5K	﹤0.01%	1548
2021 Q2	$4.34M	Sell	337,100 -10,400	-3%	-$119K	﹤0.01%	1594
2021 Q1	$3.88M	Buy	347,500 +4,300	+1%	+$45.4K	﹤0.01%	1608
2020 Q4	$3.91M	Hold	343,200	–	–	﹤0.01%	1518
2020 Q3	$3.09M	Buy	343,200 +7,700	+2%	+$76.5K	﹤0.01%	1481
2020 Q2	$3.46M	Buy	335,500 +31,400	+10%	+$321K	﹤0.01%	1373
2020 Q1	$3.07M	Buy	304,100 +4,600	+2%	+$54.1K	﹤0.01%	1194
2019 Q4	$3.99M	Buy	299,500 +7,500	+3%	+$82.7K	﹤0.01%	1302
2019 Q3	$2.51M	Buy	292,000 +4,300	+1%	+$41.8K	﹤0.01%	1527
2019 Q2	$3.15M	Sell	287,700 -17,128	-6%	-$192K	﹤0.01%	1413
2019 Q1	$3.45M	Buy	304,828 +10,985	+4%	+$123K	﹤0.01%	1323
2018 Q4	$2.55M	Sell	293,843 -21,970	-7%	-$252K	﹤0.01%	1403
2018 Q3	$4.88M	Buy	315,813 +31,283	+11%	+$495K	0.01%	1133
2018 Q2	$4.56M	Buy	284,530 +17,671	+7%	+$262K	0.01%	1172
2018 Q1	$3.45M	Buy	266,859 +5,851	+2%	+$72.9K	﹤0.01%	1285
2017 Q4	$3.28M	Buy	261,008 +9,671	+4%	+$126K	﹤0.01%	1323
2017 Q3	$3.32M	Hold	251,337	–	–	﹤0.01%	1296
2017 Q2	$3.97M	Buy	251,337 +6,209	+3%	+$90.2K	﹤0.01%	1136
2017 Q1	$3.5M	Buy	245,128 +2,865	+1%	+$39.2K	﹤0.01%	1212
2016 Q4	$3.1M	Buy	242,263 +12,299	+5%	+$155K	﹤0.01%	1271
2016 Q3	$3.06M	Sell	229,964 -7,164	-3%	-$83.8K	﹤0.01%	1232
2016 Q2	$2.6M	Sell	237,128 -8,597	-3%	-$84K	﹤0.01%	1325
2016 Q1	$2.17M	Buy	245,725 +50,745	+26%	+$419K	﹤0.01%	1396
2015 Q4	$1.89M	Hold	194,980	–	–	﹤0.01%	1382
2015 Q3	$1.7M	Buy	194,980 +25,910	+15%	+$242K	﹤0.01%	1415
2015 Q2	$1.71M	Buy	169,070 +10,984	+7%	+$128K	﹤0.01%	1421
2015 Q1	$2.12M	Buy	158,086 +4,418	+3%	+$58K	0.01%	1250
2014 Q4	$1.97M	Buy	153,668 +3,821	+3%	+$43.7K	0.01%	1267
2014 Q3	$1.63M	Hold	149,847	–	–	0.01%	1326
2014 Q2	$1.92M	Hold	149,847	–	–	0.01%	1279
2014 Q1	$1.55M	Buy	149,847 +46,327	+45%	+$521K	0.01%	1398
2013 Q4	$1.01M	Buy	103,520 +12,657	+14%	+$114K	﹤0.01%	1500
2013 Q3	$902K	Sell	90,863 -5,254	-5%	-$51.5K	﹤0.01%	1522
2013 Q2	$801K	Buy	+96,117	New	+$1.16M	﹤0.01%	1577

Other funds holding IRWD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Swiss National Bank's IRWD Position: Q2 2025 in Review

Swiss National Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 282,700 shares — an estimated $416K sold.

Swiss National Bank first reported a position in IRWD in Q2 2013 and held it in 48 quarters. The position peaked at $4.88M in Q3 2018. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

Swiss National Bank reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Swiss National Bank sold 282,700 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $416K.
Swiss National Bank first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 48 quarters.
Swiss National Bank's Ironwood Pharmaceuticals position peaked at $4.88M in Q3 2018.
155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.